
Revolutionary eye injection saved my sight, says first-ever patient
Key Points:
- Doctors at Moorfields Hospital in London have developed a pioneering treatment using a transparent, water-based gel called hydroxypropyl methylcellulose (HPMC) to restore sight and prevent blindness in patients with hypotony, a rare eye condition causing dangerously low eye pressure.
- In a pilot study, seven out of eight patients responded positively to this therapy, which is the first to effectively restore vision by filling the eye with a clear substance rather than toxic silicone oil used previously.
- Patient Nicki Guy, who lost significant vision due to hypotony, shared her life-changing experience, reporting a dramatic improvement from barely seeing to nearly meeting the legal standard for driving vision.
- The treatment works by restoring the eye’s shape and pressure, preventing the eyeball












